Get started
Author

Jingxian Ding

Observed name: Jing-Xian Ding
ORCID: 0000-0002-8242-1081
Observed ORCID: 0000-0002-8242-1081
OpenAlex ID: A5046666058
Recent Advances in Chitosan and its Derivatives in Cancer Treatment
2022 · Jingxian Ding, Yonghong Guo · Frontiers in Pharmacology · 136
PDF
Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer
2012 · Jingxian Ding, Wei Jin, et al. · PLoS ONE · 126
PDF
Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells
2009 · Xiao-Ming Bai, Hui Jiang, et al. · Life Sciences · 49
CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing
2016 · Jingxian Ding, Chungen Guo, et al. · International Journal of Oncology · 42
PDF
Polysaccharides Derived from Saposhnikovia divaricata May Suppress Breast Cancer Through Activating Macrophages
2020 · Jingxian Ding, Yonghong Guo, et al. · OncoTargets and Therapy · 20
PDF
The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women
2018 · Jingxian Ding, Yonghong Guo, et al. · OncoTargets and Therapy · 20
PDF
Immune Checkpoint Inhibitors Combined With Chemotherapy Compared With Chemotherapy Alone for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
2021 · Qiao Ji, Jingxian Ding, et al. · Frontiers in Oncology · 19
Factors influencing pathological complete response to neoadjuvant chemotherapy in resectable breast cancer: A retrospective study
2025 · Jian Kang, Huifen Xiong, et al. · Oncology Letters · 9
PDF
Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review
2020 · Jingxian Ding, Yonghong Guo, et al. · Medicine · 8
Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer
2022 · Jingxian Ding, Yali Cao, et al. · Frontiers in Oncology · 6
PDF
The prevalence of non-sentinel lymph node metastasis among breast cancer patients with sentinel lymph node involvement and its impact on clinical decision-making: a single-centred retrospective study
2024 · Jingxian Ding, Xiaoliu Jiang, et al. · Oncology Reviews · 5
PDF
The prevalence and genetic disorders spectrum of thalassemia among breast cancer patients in Jiangxi province, China
2022 · Jingxian Ding, Zhaohui Huang, et al. · Frontiers in Genetics · 5
PDF
The importance of tissue confirmation of metastatic disease in patients with breast cancer: lesson from a brain metastasis case
2016 · Jingxian Ding, Pinghua Hu, et al. · Oncoscience · 4
PDF
Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer: Development and Validation of a Clinical-Inflammatory Nomogram
2026 · Xiaoliu Jiang, Zhaohui Huang, et al. · Annals of Surgical Oncology · 1
PDF
ASO Author Reflections: Toward Personalized Neoadjuvant Therapy in HER2-Positive Breast Cancer—A Clinically Actionable Predictive Model
2026 · Xiaoliu Jiang, Zhaohui Huang, et al. · Annals of Surgical Oncology
ERK knockdown suppress cell biological activities via regulation CD59 in breast cancer
2021 · Fei Qu, Yanru Cui, et al. · Archives of Medical Science
PDF
Role of ERCC1 in cisplatin resistance in esophageal cancer
2013 · Hong-Li Zhao, Sha Han, et al. · World Chinese Journal of Digestology
Works count: 17
Citation count: 450
H-index: 8
I10-index: 7
Year
Topic
Type